Home › Funds › Spruce Street Capital LP › PCVX

Spruce Street Capital LP position in PCVX

VAXCYTE INC · Health Care

Spruce Street Capital LP reported holding 306,047 shares of PCVX (VAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$17.4M, representing 2.77% of its reported portfolio and ranking #11 among its reported holdings. Spruce Street Capital LP has disclosed PCVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)306.05K sh
Reported value held$17.41M
Portfolio Weight2.77%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's PCVX position evolved

Spruce Street Capital LP first disclosed a stake in PCVX in Q4 2025 at 400,360 shares (US$18.5M). Across 4 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 306,047 shares valued at US$17.4M. Notable position changes include a 39% trim in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 400.36K $18.47M New
Q1 2026 245.71K $14.28M Reduce
Q2 2026 306.05K $17.79M Add
Q3 2026 306.05K $17.41M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 33 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has Spruce Street Capital LP held PCVX?

Spruce Street Capital LP has disclosed PCVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in PCVX?

As of Q3 2026, Spruce Street Capital LP holds 306.05K shares of PCVX (VAXCYTE INC), valued at $17.41M, representing 2.77% of its reported portfolio and ranking #11.

Has Spruce Street Capital LP been buying or selling PCVX?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in PCVX.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.